On CNBC's “Halftime Report Final Trades,” Kevin Simpson of Capital Wealth Planning said Meta Platforms, Inc. (NASDAQ:META) is hitting on all cylinders.

On Sept. 26, Rosenblatt analyst Barton Crockett maintained Meta Platforms with a Buy and raised the price target from $643 to $811.

Brenda Vingiello of Sand Hill Global Advisors named Accenture plc (NYSE:ACN) as her final trade.

On Sept. 26, Accenture reported fourth-quarter fiscal 2024 sales of $16.41 billion compared with the analyst consensus estimate of $16.39 billion, up 3% Y/Y in U.S. dollars and 5% in local currency. Revenues were above the midpoint of the company's guided range of $16.05 billion–$16.65 billion. The adjusted EPS of $2.79 topped the analyst consensus estimate of $2.77.

Don't forget to check out our premarket coverage here

Jason Snipe of Odyssey Capital Advisors said AbbVie Inc. (NYSE:ABBV) has a great pipeline.

On Sept. 26, AbbVie released topline results from its pivotal Phase 3 TEMPO-1 trial for tavapadon as a monotherapy in early Parkinson's disease.

Joseph M. Terranova of Virtus Investment Partners picked Walt Disney Company (NYSE:DIS), saying streaming profitability is going to be a lot higher than expected for the next year.

Walt Disney let go of at least 300 employees across multiple corporate departments. "We continually evaluate ways to invest in our businesses and more effectively manage our resources and costs to fuel the state-of-the-art creativity and innovation that consumers value and expect from Disney," Variety cites a company representative. The layoffs affected human resources, legal, finance and other departments in the U.S.

Price Action:

• Meta shares fell 0.1% to close at $567.36 during Friday's session.
• Accenture shares fell 1.7% to settle at $349.70 on Friday.
• AbbVie shares gained 1.5% to close at $194.79 during Friday's session.
• Disney shares gained 0.9% to close at $96.01 on Friday.

Check This Out:

• Top 4 Materials Stocks That May Implode In Q3

Image: Shutterstock